These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2114786

  • 21. Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia.
    Chantorn R, Shwayder T.
    Pediatr Dermatol; 2012; 29(5):605-9. PubMed ID: 22329485
    [Abstract] [Full Text] [Related]

  • 22. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI.
    Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, Rao VK, Metcalfe DD.
    Leuk Res; 2003 Aug; 27(8):677-82. PubMed ID: 12801524
    [Abstract] [Full Text] [Related]

  • 23. Mast cell sarcoma: new cases and literature review.
    Monnier J, Georgin-Lavialle S, Canioni D, Lhermitte L, Soussan M, Arock M, Bruneau J, Dubreuil P, Bodemer C, Chandesris MO, Lortholary O, Hermine O, Damaj G.
    Oncotarget; 2016 Oct 04; 7(40):66299-66309. PubMed ID: 27602777
    [Abstract] [Full Text] [Related]

  • 24. Urinary N-methylhistamine as an indicator of bone marrow involvement in mastocytosis.
    Oranje AP, Mulder PG, Heide R, Tank B, Riezebos P, van Toorenenbergen AW.
    Clin Exp Dermatol; 2002 Sep 04; 27(6):502-6. PubMed ID: 12372095
    [Abstract] [Full Text] [Related]

  • 25. Systemic mastocytosis and probable mast cell leukaemia in a koala (Phascolarctos cinereus).
    Phillips CA, Jaensch S, Hayward D.
    Aust Vet J; 2020 Mar 04; 98(3):96-99. PubMed ID: 31919836
    [Abstract] [Full Text] [Related]

  • 26. Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma.
    Auquit-Auckbur I, Lazar C, Deneuve S, Guillemet C, Cordel N, Blanchard F, Joly P, Courville P.
    Am J Surg Pathol; 2012 May 04; 36(5):779-82. PubMed ID: 22498828
    [Abstract] [Full Text] [Related]

  • 27. Bone marrow findings in systemic mastocytosis.
    Horny HP, Parwaresch MR, Lennert K.
    Hum Pathol; 1985 Aug 04; 16(8):808-14. PubMed ID: 3860469
    [Abstract] [Full Text] [Related]

  • 28. Myelomastocytic Leukemia With t(8;21) in a 3-year-old Child.
    Intzes S, Wiersma S, Meyerson HJ.
    J Pediatr Hematol Oncol; 2011 Dec 04; 33(8):e372-5. PubMed ID: 22042288
    [Abstract] [Full Text] [Related]

  • 29. Rapid engraftment of mast cells of donor origin in a case of acute myeloid leukemia with mast cell leukemia after allogeneic stem cell transplantation.
    Chen TY, Chen JS, Huang WT, Su WC, Tsao CJ.
    Bone Marrow Transplant; 2003 Jul 04; 32(1):111-4. PubMed ID: 12815487
    [Abstract] [Full Text] [Related]

  • 30. [The mast cell].
    Grabbe J, Haas N, Czarnetzki BM.
    HNO; 1994 Jun 04; 42(6):375-84. PubMed ID: 8071100
    [No Abstract] [Full Text] [Related]

  • 31. The spectrum of mastocytosis.
    Tharp MD.
    Am J Med Sci; 1985 Mar 04; 289(3):119-32. PubMed ID: 2579553
    [Abstract] [Full Text] [Related]

  • 32. Molecular genetics and development of mast cells: implications for molecular medicine.
    Födinger M, Mannhalter C.
    Mol Med Today; 1997 Mar 04; 3(3):131-7. PubMed ID: 9095488
    [Abstract] [Full Text] [Related]

  • 33. Combined melanocytoma-mastocytoma in a case of nodular mastocytosis.
    Okun MR, Bhawan J.
    J Am Acad Dermatol; 1979 Oct 04; 1(4):338-47. PubMed ID: 117029
    [Abstract] [Full Text] [Related]

  • 34. Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?
    Falleti J, Borgia L, Lalinga AV, De Cecio R, Natella V, Patitucci G, Vita G.
    Pathol Res Pract; 2012 Nov 15; 208(11):683-6. PubMed ID: 22963840
    [Abstract] [Full Text] [Related]

  • 35. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
    Lawrence JB, Friedman BS, Travis WD, Chinchilli VM, Metcalfe DD, Gralnick HR.
    Am J Med; 1991 Dec 15; 91(6):612-24. PubMed ID: 1750431
    [Abstract] [Full Text] [Related]

  • 36. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, Mateo MB, Alonso Díaz de Durana MD, de la Hoz B, Del Pozo Gil MD, Caballero T, Rosado A, Sánchez Matas I, Teodósio C, Jara-Acevedo M, Mollejo M, García-Montero A, Orfao A, Escribano L.
    J Allergy Clin Immunol; 2010 Jun 15; 125(6):1269-1278.e2. PubMed ID: 20434205
    [Abstract] [Full Text] [Related]

  • 37. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P, Horny HP.
    Leuk Lymphoma; 2003 Feb 15; 44(2):313-9. PubMed ID: 12688351
    [Abstract] [Full Text] [Related]

  • 38. Pharmacological treatment options for mast cell activation disease.
    Molderings GJ, Haenisch B, Brettner S, Homann J, Menzen M, Dumoulin FL, Panse J, Butterfield J, Afrin LB.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul 15; 389(7):671-94. PubMed ID: 27132234
    [Abstract] [Full Text] [Related]

  • 39. Malignant systemic mastocytosis.
    Abraham EK, Augustine J, Amma S, Nair K.
    Indian J Cancer; 1992 Dec 15; 29(4):192-7. PubMed ID: 1293004
    [Abstract] [Full Text] [Related]

  • 40. Indolent systemic mastocytosis as the cause of a long history of unexplained hypotensive episodes.
    Nora EH, Hamacher KL, Zent CS, Ghosh AK.
    South Med J; 2006 Aug 15; 99(8):876-9. PubMed ID: 16929885
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.